NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE PODIATRY SOCIETY OF THE STATE OF NY D/B/A THE FDN FOR PODIATRIC MEDICINE, founded in 1986, is a small nonprofit in the Health Care sector that reported $361K in total revenue in fiscal year 2024. Revenue decreased 16% compared to the prior year. Expenses of $421K exceeded revenue, resulting in a 17% operating deficit.
THE MISSION OF THE PODIATRY SOCIETY OF THE STATE OF NY IS TO DEVELOP, SPONSOR, AND CONDUCT INFORMATIONAL PROGRAMS IN THE FIELD OF PODIATRIC MEDICINE FOR THE CONTINUING EDUCATION OF PODIATRIC MEDICAL PRACTITIONERS; TO DEVELOP, SPONSOR AND CONDUCT INFORMATIONAL PROGRAMS IN ORDER TO EDUCATE THE PUBLIC AS TO THE NATURE AND BENEFITS OF PODIATRIC MEDICAL CARE; TO DEVELOP, SPONSOR, SUPPORT AND MAINTAIN EDUCATIONAL PROGRAMS, FACILITIES AND MATERIALS SUCH AS REFERENCE MATERIALS AND LIBRARY FACILITIES FOR THE ADVANCEMENT OF KNOWLEDGE AND SCHOLARSHIP IN THE FIELD OF PODIATRIC MEDICINE; AND TO SPONSOR RESEARCH AND DEVELOPMENT IN THE FIELD OF PODIATRIC MEDICINE.
IN KEEPING WITH ITS MISSION, THE FOUNDATION FOR PODIATRIC MEDICINE HONORS THE TRADITION OF ADVANCING THE PROFESSION THROUGH EDUCATION. ITS PREMIER EDUCATIONAL EVENT, THE CLINICAL CONFERENCE, GATHERS...
IN KEEPING WITH ITS MISSION, THE FOUNDATION FOR PODIATRIC MEDICINE HONORS THE TRADITION OF ADVANCING THE PROFESSION THROUGH EDUCATION. ITS PREMIER EDUCATIONAL EVENT, THE CLINICAL CONFERENCE, GATHERS THE BEST AND BRIGHTEST FACULTY TO PRESENT THE VITAL EDUCATIONAL AND CLINICAL INFORMATION THAT IS SO IMPORTANT TO PODIATRISTS. THE CLINICAL CONFERENCE ENSURES BOTH QUALITY PATIENT CARE AND THE CONTINUING GROWTH OF THE PROFESSION.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $360,571 | $431,083 | -0.2% |
| Expenses | $420,803 | $456,646 | -0.1% |
| Net Income | $-60,232 | $-25,563 | +1.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DR DANIEL KEATING | PRESIDENT | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DR CHARLES LOMBARDI | VICE PRESIDENT | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DR WILLIAM SPIELFOGEL | TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DR LAUREN SCHWARTZ | SECRETARY | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DR NICHOLAS ARGERAKIS | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| DR EMILIO GOEZ | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| DR JAMES HANNA | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| DR JACKIE PREVETE | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| DR PAUL LISWOOD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| RYAN ROSENBAUM | EXECUTIVE DIRECTOR (THRU 4/25) | 10.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $360,571 | $420,803 | $137,966 | $-60,232 |
| 2024 | $431,083 | $456,646 | $288,296 | $-25,563 |
| 2023 | $420,744 | $498,145 | $194,312 | $-77,401 |
| 2022 | $208,364 | $272,800 | $301,839 | $-64,436 |
| 2021 | $202,796 | $225,648 | $350,120 | $-22,852 |
| 2020 | $483,905 | $477,318 | $352,903 | $6,587 |
| 2019 | $509,902 | $496,859 | $402,836 | $13,043 |
| 2018 | $520,236 | $513,791 | $358,931 | $6,445 |
Compare THE PODIATRY SOCIETY OF THE STATE OF NY D/B/A THE FDN FOR PODIATRIC MEDICINE with other nonprofits in New York and across the country.